Pet Ownership to Preserve Cognitive Ability - Quick Reference Sheet

Pet Ownership to Preserve Cognitive Ability

Created on 09/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 Audit

Keeping a companion animal bundles movement, routine, touch and social exchange. Large population studies show owners, dog owners especially, declining more slowly on memory and word-finding tests, the gap largest among people living alone. No one has assigned animals at random, so healthier people simply keeping more pets is not ruled out. Costs: broken bones, infection, asthma, disturbed sleep, grief. (Full Review)

Protocol

Core regimen
30 min daily dog walking
Temperament-assessed animal matched to household mobility; fixed care routine
Split rather than single exposure
2 bouts of 15–20 min
Morning and late afternoon; a single weekend walk does not substitute
Best time of day
Within 2 h of waking
Outdoor morning walk pairs activity with bright light, aiding circadian timing
Time to effect
Verbal memory and fluency
8–13 years
Shallower decline on word-recall and word-generation tests
Disabling dementia
4 years
Lower incidence in current dog owners over cohort follow-up
Walking volume and routine
2–4 weeks
Walking and routine change; no cognitive change detected over months

Benefits

Contraindications
  • Absent or non-functioning spleen (splenectomy, sickle cell disease, hyposplenism)
  • Absolute neutrophil count persistently below 500 per microlitre
  • Solid-organ transplantation within 6 months, or maintenance prednisone ≥20 mg daily
  • Severe persistent asthma (Global Initiative for Asthma step 4–5) with cat or dog sensitisation
  • Established osteoporosis (T-score ≤ −2.5) with prior fracture, for dogs above 15 kg or untrained
  • Advanced dementia (Clinical Dementia Rating ≥2) without a co-resident caregiver
  • Pregnancy, for litter-box handling specifically
  • Cell-killing chemotherapy and neutropenia, for waste handling while counts are lowest
Key Interactions
  • Immunosuppressants (tacrolimus, mycophenolate, prednisone ≥20 mg daily for ≥2 weeks), for litter handling
  • Tumour necrosis factor inhibitors (infliximab, adalimumab, etanercept)
  • Oral anticoagulants (warfarin, apixaban, rivaroxaban)
  • Sedative-hypnotics and anticholinergic drugs (zolpidem, diphenhydramine, oxybutynin)
  • Over-the-counter allergy and pain medication (diphenhydramine, chlorphenamine, ibuprofen)
  • Supplement interactions (melatonin, valerian, high-dose magnesium at night)
  • Supplements with additive effects (potassium, magnesium, beetroot nitrate, hibiscus, garlic)

Risk & Side Effects

  • Medium: Fall, fracture and head injury during dog walking; modestly higher depression risk in cat owners; asthma attacks in sensitised owners
  • Low: Zoonotic infection; cognitive effects of Toxoplasma gondii; higher odds of schizophrenia-related disorders in cat owners; sleep disruption from bed-sharing; caregiving strain and grief after the animal's death

Monitoring

Marker Target Why
Montreal Cognitive Assessment ≥26 of 30 Global cognitive screen, the primary endpoint
Verbal fluency, animal naming in 60 seconds ≥17 words Where the pet-ownership signal appears
Usual gait speed, 4-metre walk ≥1.0 m/s Slow gait precedes decline and predicts falls
Daily step count 7,000–10,000 steps/day Quantifies dog-walking exposure objectively
Systolic blood pressure 110–125 mmHg Midlife hypertension is a dementia risk factor
Bone mineral density T-score ≥ −1.0 Fracture consequence of a pull-related fall
High-sensitivity C-reactive protein <1.0 mg/L Inflammatory load; rises with airway allergy and infection
Absolute neutrophil count 1,800–7,000 per microlitre Susceptibility to animal-borne infection
Total and animal-specific immunoglobulin E Total <100 IU/mL; cat and dog specific negative Allergic sensitisation driving airway inflammation and poor sleep
Toxoplasma gondii immunoglobulin G Negative Prior exposure before a cat enters the household

Cadence: Step count and sleep continuously or monthly; blood pressure every 3 months; cognitive and mobility measures at 12 months and annually thereafter; bone density every 2 years where abnormal at baseline.

Qualitative Assessment

  • Ease of word-finding in conversation, and whether names are retrieved more slowly than a year earlier
  • Subjective sleep quality and number of night-time awakenings attributable to the animal
  • Daytime energy and willingness to take the second walk rather than only the first
  • Mood, and whether time with the animal still registers as pleasurable rather than obligatory
  • Felt loneliness on days with and without human contact
  • Caregiving strain: whether veterinary costs or behavioural problems generate persistent worry